National trends (2003-2009) and factors related to psychotropic medication use in community-dwelling elderly population

International Psychogeriatrics

Volumn 25, Issue 2, 2013, Pages 328-338

  Carrasco Garrido, P ^a   Lopez De Andres A ^a   Barrera, V Hernández ^a   Jiménez Trujillo, Isabel ^a   Jimenez Garcia R ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

elderly; gender; national survey; polypharmacy; psychotropic medication

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

AGED; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE TO HEALTH; COMMUNITY LIVING; COMORBIDITY; CONSULTATION; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; SEX DIFFERENCE; SPAIN; TREND STUDY;

AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; DEMOGRAPHY; DEPRESSIVE DISORDER; DRUG UTILIZATION; FEMALE; HEALTH SURVEYS; HUMANS; INDEPENDENT LIVING; MALE; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; PSYCHOTROPIC DRUGS; SOCIOECONOMIC FACTORS; SPAIN;

EID: 84871526837     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S104161021200169X     Document Type: Article

References (38)

1. Akazawa, M., Imai, H., Igarashi, A. and Tsutani, K. (2010). Potentially inappropriate medication use in elderly Japanese patients. American Journal of Geriatric Pharmacotherapy, 8, 146-160.
2. Blasco, F., López de Letona, J., Villares, P. and Jiménez, A. I. (2005). El paciente anciano polimedicado: efectos sobre su salud y sobre el sistema sanitario. Información Terapéutica del Sistema Nacional de Salud, 29, 152-162.
3. Blumstein, T., Benyamini, Y., Chetrit, A., Mizrahi, E. H. and Lerner-Geva, L. (2012). Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart. Aging and Mental Health, 16, 636-647.
4. Carrasco-Garrido, P., Jiménez-García, R., Astasio-Arbiza, P., Ortega-Molina, P. and de Miguel, A. G. (2007). Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003. Pharmacoepidemiology and Drug Safety, 16, 449-457.
5. Codony, M. et al. (2007). Psychotropic medications use in Spain: results of the ESEMeD-Spain study. Actas Españolas de Psiquiatría, 35, 29-36.
6. Covinsky, K. E., Yaffe, K., Lindquist, K., Cherkasova, E., Yelin, E. and Blazer, D. G. (2010). Depressive symptoms in middle age and the development of later-life functional limitations: the long-term effect of depressive symptoms. Journal of American Geriatric Society, 58, 551-556.
7. Crentsil, V., Ricks, M. O., Xue, Q. L. and Fried, L. P. (2010). A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. American Journal of Geriatric Pharmacotherapy, 8, 215-224.
8. Demyttenaere, K. et al. (2008). Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). Journal of Affective Disorders, 110, 84-93.
9. Desplenter, F., Caenen, C., Meelberghs, J., Hartikainen, S., Sulkava, R. and Bell, J. S. (2011). Change in psychotropic drug use among community-dwelling people aged 75 years and older in Finland: repeated cross-sectional population studies. International Psychogeriatrics, 23, 1278-1284.
10. Fortin, D. et al. (2005). Factors associated with short-and long-term use of benzodiazepines in the elderly from Quebec. Canadian Journal of Aging, 24, 103-113.
11. Fourrier, A., Letenneur, L., Dartigues, J. F., Moore, N. and Begaud, B. (2001). Benzodiazepine use in an elderly community-dwelling population: characteristic of users and factors associated with subsequent use. European Journal of Clinical Pharmacology, 57, 419-425.
12. Gabilondo, A. et al. (2010). Epidemiology of major depressive episode in a southern European country: results from the ESEMeD-Spain project. Journal of Affective Disorders, 12, 76-85.
13. Hämäläinen, J., Isometsä, E., Sihvo, S., Kiviruusu, O., Pirkola, S. and Lönnqvist, J. (2009). Treatment of major depressive disorder in the Finnish general population. Depression and Anxiety, 26, 1049-1059.
14. Haro, J. M. et al. (2006). Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study. Medicina Clínica, 126, 445-451.
15. INE (Instituto Nacional de Estadística). (2005). Encuesta Nacional de Salud de España 2003 (Spanish National Health Survey 2003). Available at: http://www.ine. es/en/metodologia/t15/t1530419-en.pdf.
16. INE. (2008). Encuesta Nacional de Salud de España 2006 (Spanish National Health Survey 2006). Available at: http://www.ine.es/jaxi/menu.do?L= 0&type=pcaxis&path=/t15/p419&file=inebase.
17. INE. (2011). Encuesta Europea de Salud para España 2009 (European Health Survey for Spain 2009). Available at: http://www.msc.es/estadEstudios/ estadisticas/EncuestaEuropea/Metodologia-EES-2009.pdf.
18. Jónsdóttir, H. et al. (2010). Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. Journal of Clinical Psychopharmacology, 30, 169-175.
19. Kairuz, T. et al. (2008). Identifying compliance issues with prescription medicines among older people: a pilot study. Drug and Aging, 25, 153-162.
20. King-Kallimanis, B., Gum, A. M. and Kohn, R. (2009). Comorbidity of depressive and anxiety disorders for older Americans in the national comorbidity survey-replication. American Journal of Geriatric Psychiatry, 17, 782-792.
21. Lai, H. Y., Hwang, S. J., Chen, Y. C., Chen, T. J., Lin, M. H. and Chen, L. K. (2009). Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clinical Therapeutics, 31, 1859-1870.
22. Lesén, E., Andersson, K., Petzold, M. and Carlsten, A. (2010). Socioeconomic determinants of psychotropic drug utilization among elderly: a national population-based cross-sectional study. BMC Public Health, 10, 118.
23. Marengoni, A. et al. (2011). Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients. International Psychogeriatrics, 8, 1-8.
24. Mastroianni, P. C., Vaz, A. C., Noto, A. R. and Galduróz, J. C. (2008). Psychoactive drug advertising: content analysis. Revista de Saude Publica, 42, 968-971.
25. Ministerio de Sanidad, Servicios Sociales e Igualdad. (2006). Subgrupos ATC y Principios activos de mayor consumo en el Sistema Nacional de Salud en 2005. Información Terapéutica del Sistema Nacional de Salud. Available at: http://www.msssi.gob.es/biblioPublic/publicaciones/recursos- propios/infMedic/docs/SubgruposATCvol35n4.pdf.
26. Ministerio de Sanidad, Servicios Sociales e Igualdad. (2011). Subgrupos ATC y Principios activos de mayor consumo en el Sistema Nacional de Salud en 2010. Información Terapéutica del Sistema Nacional de Salud. Available at: http://www.msssi.gob.es/biblioPublic/publicaciones/docs/ subgruposAtc.pdf.
27. Mojtabai, R. and Olfson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67, 26-36.
28. Ohayon, M. M. (2007). Epidemiology of depression and its treatment in the general population. Journal of Psychiatric Research, 41, 207-213.
29. Patten, S. B., Williams, J. V., Lavorato, D. H., Khaled, S. and Bulloch, A. G. (2011). Weight gain in relation to major depression and antidepressant medication use. Journal of Affective Disorders, 134, 288-293.
30. Paulose-Ram, R., Safran, M. A., Jonas, B. S., Gu, Q. and Orwig, D. (2007). Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiology and Drug Safety, 16, 560-570.
31. Payne, R. A. and Avery, A. J. (2011). Polypharmacy: one of the greatest prescribing challenges in general practice. British Journal of General Practice, 61, 83-84.
32. Pélissolo, A., Maniere, F., Boutges, B., Allouche, M., Richard-Berthe, C. and Corruble, E. (2007). Anxiety and depressive disorders in 4, 425 long term benzodiazepine users in general practice. Encephale, 33, 32-38.
33. Rikala, M., Korhonen, M. J., Sulkava, R. and Hartikainen, S. (2011). Psychotropic drug use in community-dwelling elderly people: characteristics of persistent and incident users. European Journal of Clinical Pharmacology, 67, 731-739.
34. Ruiz-Cantero, M. T. and Verdú-Delgado, M. (2004). Gender bias in treatment. Gaceta Sanitaria, 18, 118-125.
35. Soudry, A., Dufouil, C., Ritchie, K., Dartigues, J. F., Tzourio, C. and Alpérovitch, A. (2008). Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study. European Journal of Clinical Pharmacology, 64, 51-59.
36. Tordoff, J., Simonsen, K., Thomson, W. M. and Norris, P. T. (2010). "It's just routine": a qualitative study of medicine-taking amongst older people in New Zealand. Pharmacy World Sciences, 32, 154-161.
37. Voyer, P., Preville, M., Roussel, M. E., Berbiche, D. and Beland, S. G. (2009). Factors associated with benzodiazepine dependence among community-dwelling seniors. Journal of Community Health Nursing, 26, 101-113.
38. Zhang, Y. et al. (2010). Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing. International Psychogeriatrics, 22, 437-444.